In mice bearing SCC tumors, pharmacological FAK inhibition led to a decrease in Treg recruitment and an increase in cytotoxic CD8+ T cells21, demonstrating that pharmacological FAK inhibitors can promote active immune surveillance in the TME to prevent tumor progression. Here, PTK2 is linked to neoplasm.